AstraZeneca (NASDAQ: AZN) and Pfizer (NYSE: PFE) -- along with one biotech stock, Exelixis (NASDAQ: EXEL). (AstraZeneca): ...

Leon Wang, the president of AstraZeneca’s China division, was last year detained alongside several other employees amid an investigation into operations in the country. Authorities are looking ...

AstraZeneca has offered Harbour up to $175 million in an upfront payment, near-term milestones and option exercise fees. The deal, which features up to $4.4 billion in additional milestones ...

On October 30, AstraZeneca announced that Mr. Wang was cooperating with a Chinese investigation, offering few details. This initial announcement triggered a 3 percent drop in the company's share ...

On October 30, AstraZeneca announced that Mr. Wang was cooperating with a Chinese investigation, offering few details. This initial announcement triggered a 3 percent drop in the company's share ...

More recently, on December 18, The Financial Times reported that AstraZeneca executives anticipate a decline in Chinese revenue due to the arrests of Mr. Wang and other senior executives.

The situation escalated with the arrest of Leon Wang, AstraZeneca's Executive Vice President International and China President. This development, coupled with internal forecasts predicting a downturn ...

The truth allegedly began to emerge in late October. On October 30, AstraZeneca announced that Mr. Wang was cooperating with a Chinese investigation, offering few details.

The situation escalated with the arrest of Leon Wang, AstraZeneca’s Executive Vice President International and China President. This development, coupled with internal forecasts predicting a ...

More recently, on December 18, The Financial Times reported that AstraZeneca executives anticipate a decline in Chinese revenue due to the arrests of Mr. Wang and other senior executives.